< Zurück zu den aktuellen Neuigkeiten & Events

Veranstaltungen

IP in Healthcare Conference 2020

März 2020

Veranstaltungsdatum: 3. März 2020

March 2020 in London and Manchester. HGF’s sixth annual Healthcare Conference reviews the latest intellectual property issues in the pharmaceuticals, life sciences and medical devices sectors.

Update

It is with great regret that we have taken the decision to cancel the HGF IP in Healthcare conference in London on Thursday 12th March. This is a precautionary measure by the firm based on current situation surrounding the Coronavirus in the UK and Europe.

We would like to take this opportunity to thank you for reserving your place and we look forward to welcoming you again in 2021.

Dates

The Conference will take place on the following dates:

  • Tuesday 3rd March in Alderley Park, Manchester
  • Thursday 12th March in Barber-Surgeons Hall, London *Cancelled*
About HGF Healthcare team

HGF’s Healthcare team provides professional expertise and commercially focused advice to business leaders and decision makers in the healthcare fields of life sciences, pharmaceuticals and medical devices. HGF has in-depth knowledge of the sector, and the experience to provide you with high quality and commercially focused advice in relation to the protection of your IP rights. The team offers the full range of IP services including:

  • IP strategy and advice;
  • Patent and trade mark procurement;
  • IP portfolio management;
  • Freedom-to-operate advice and opinions;
  • IP due diligence assessments and opinions;
  • Supplementary protection certificates and data exclusivity advice;
  • IP licences and agreements;
  • IP disputes management and litigation

For more information on the team please click here.

Please join our Healthcare+IP LinkedIn group which discusses stories and legal developments in the intellectual property field which impacts the healthcare sector.

Aktuelle Neuigkeiten

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Weiterlesen

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Weiterlesen
Event - 14. Oktober 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Veranstaltungsdetails

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Weiterlesen

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Weiterlesen

HGF hoch platziert im Legal 500 2026

Die Rangliste des Legal 500 UK 2026 wurde veröffentlicht und HGF wurde erneut in mehreren Regionen und Praxisbereichen platziert. HGF ist weiterhin in der Spitzenklasse des britischen PATMA – Markenzeichen …

Weiterlesen

12 Anwälte von HGF als „Managing IP Rising Stars 2025” ausgezeichnet

Wir sind sehr stolz darauf, bekannt geben zu dürfen, dass 12 unserer Anwälte in den aktuellen „Managing IP Rankings” als „Rising Stars” ausgezeichnet wurden! Diese Auszeichnung würdigt die nächste Generation …

Weiterlesen

IP Ingredients: The companies making – and patenting - alt coffee

How do you like your coffee? Frothy or flat? Milky or black? Oat-milk or soy?  How about coffee which isn’t derived from coffee beans? Coffee is the second most traded …

Weiterlesen